Novo nordisk News: Novo nordisk Latest News, Novo nordisk Today news, Novo nordisk Breaking News

‘This is only the beginning of the GLP-1 journey in India’: Vikrant Shrotriya, MD of Novo Nordisk India

Novo Nordisk India MD Vikrant Shrotriya discusses navigating the post-patent semaglutide generic influx, the massive underpenetration of GLP-1 therapies, and…

July 10, 2026 05:30 IST

‘Automation is reshaping, not shrinking talent’ Q&A with John Dawber, VP, GBS Novo Nordisk

Automation and emerging technologies are reshaping the future of work rather than shrinking opportunities, says John Dawber, vice-president & managing…

Updated: June 29, 2026 05:19 IST

Novo Nordisk cuts prices of Wegovy by 48% as competition intensifies in India’s weight-loss drug market

Novo Nordisk cuts prices of Wegovy and Ozempic in India by up to 48% amid rising competition from cheaper semaglutide…

March 31, 2026 22:38 IST

₹1,000 cr to ₹5,000 cr: 3 pharma stocks to watch for India’s GLP-1 explosion by 2030

A ₹1,000 crore market is set to grow 5x to ₹5,000 crore by 2030 as prices drop 40–50% post patent…

March 31, 2026 05:27 IST

Novo Nordisk vs Eli Lilly: Why the ‘king of weight loss’ just lost its crown

Novo Nordisk’s next-gen obesity drug CagriSema failed to match Eli Lilly’s Zepbound in a head-to-head trial, sending shares down 16%…

February 24, 2026 21:47 IST

The $100 billion pill: Why Novo Nordisk’s weight-loss breakthrough Is tanking its stock

Novo Nordisk just warned that sales could fall by 13% in 2026, sending its stock crashing nearly 20%. The culprit?…

February 4, 2026 17:11 IST

Novo Nordisk Rockets 25% in a Month: But Should You Buy the Rally?

Novo Nordisk shares have surged on the back of its groundbreaking oral Wegovy approval, making it the first company to…

January 16, 2026 18:26 IST

Explained: Why Novo Nordisk is offering the Wegovy pill at $149 a month

Novo Nordisk offers Wegovy weight-loss pill in the US at $149 per month for self-pay patients, expanding access to oral…

January 5, 2026 16:32 IST

Novo Nordisk jumped 9% in a single day. Here’s the pill that did it

Novo Nordisk shares surged nearly 9% in a single session after a key regulatory development in the US. The move…

Updated: December 24, 2025 18:59 IST

FDA approves Novo Nordisk’s popular weight-loss drug Wegovy's daily pill version

FDA approves daily pill version of Novo Nordisk’s weight-loss drug Wegovy – How much will it cost?

Novo Nordisk’s US medical lead, Dr Jason Brett, told CNN that the pill is expected to give patients more choices…

December 23, 2025 07:15 IST

Ozempic India launch, Ozempic weight loss drug India, Ozempic for type 2 diabetes, semaglutide India, Novo Nordisk Ozempic India, Ozempic price in India, Ozempic diabetes medication, Ozempic cardiovascular benefits, Ozempic chronic kidney disease benefit, Ozempic side effects, semaglutide weight loss India, Ozempic patent expiry India, Ozempic generic competition, Novo Nordisk India MD Vikrant Shrotriya, Ozempic vs Wegovy, diabetes drugs India, GLP-1 receptor agonist India, weight loss injections India, obesity treatment India, type 2 diabetes treatment India, Ozempic users worldwide, Ozempic supply India, insulin pricing India, Ryzodeg insulin Novo Nordisk, diabetes medicine pricing India, Ozempic misuse concerns, Ozempic doctor prescription India, Ozempic pharmacovigilance, Ozempic demand India

Ozempic pricing explained: Novo Nordisk India Head says, ‘we’ll drive science and stay competitive’

Vikrant Shrotriya, Novo Nordisk India MD responds to questions on future pricing, generics competition post patent expiry in March, Indian-specific…

Updated: January 11, 2026 10:59 IST

Ozempic launch & beyond: Weight-loss matters, say doctors while appetite builds for generics-led price cuts

The class of GLP-1 agonist medications act by lowering the appetite with applications way beyond diabetes. These medicines will be…

December 13, 2025 07:27 IST

Ozempic launched in India, prices start at Rs 8,800 per month

Danish drugmaker Novo Nordisk has brought its popular weight loss drug Ozempic to India. Check out prices for all doses.

Updated: January 11, 2026 10:39 IST

100 million Indians could be on GLP-1 drugs by 2030: Healthify CEO

” We are doing $1-2 million run rate revenue in the US. We expect the US business to be larger…

Updated: December 3, 2025 22:36 IST

Novo Nordisk stock plunges to a four-year-low. Here is the reason behind the slump

Novo Nordisk shares plunge after semaglutide Alzheimer’s trial fails to meet its main goal, deepening pressure amid competition, leadership shifts…

November 24, 2025 21:08 IST

Layoffs 2025: The job cuts follow similar moves by Oracle, Microsoft, and other companies that have recently let go of thousands of employees.

Novo Nordisk partners Emcure Pharma for weight loss medicine Poviztra in India

This collaboration combines Novo Nordisk’s innovation in GLP-1 therapies with Emcure’s marketing and distribution strengths to improve access to obesity…

November 10, 2025 23:17 IST